The CFDA is cracking down on false advertising, and information about certain drugs will not be allowed to be published online.
The marketing claims of some cosmetics sold online prompted the China Food and Drug Administration to publish a draft regulation on Nov. 15th.
The regulation requires online cosmetic sellers to provide adequate lab and evaluation data for the marketing claims of their products as well as trading platforms to check the qualifications of cosmetics and drug sellers.
China has over 630 million Internet users and this rule will prohibit producers and wholesalers to sell products to online consumers, and will require sellers of food, health food, cosmetics, and medical apparatus and instruments to obtain permits.
Moreover, online shopping website operators are required to compensate consumers if the operators can't provide the identity and contact information of the cosmetic seller to the consumer once complaints occur.
Online cosmetics retailer Jumei found itself in the spotlight this summer after media reports claimed it was selling fake luxury goods in China.
Brands were copied and sold through the third party retailer included Armani, Hermes and Burberry, according to the investigative report carried out by China technology news provider tech.qq.com.
Jumei stated it had shut down the offending third party online store and removed all products from sale, according to a report in The South China Morning Post.
The company in question had been able to provide Jumei with product authentication and customs certificates, which it says is now the key focus of an internal investigation into the shortcomings.
“We sincerely apologise to all customers who bought from the supplier and will provide non-conditional product return services,” said Jumei.
When news of the report broke, JD.com and Jumei were first to react, with JD.com taking action to stop the sale off all products by the third party retailer with immediate effect.